160 related articles for article (PubMed ID: 38071502)
1. Identification and validation of N
Li J; Zheng L; Song L; Dong Z; Bai W; Qi L
J Cell Mol Med; 2024 Jan; 28(2):e18067. PubMed ID: 38071502
[TBL] [Abstract][Full Text] [Related]
2. Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer.
Li T; Chen Z; Wang Z; Lu J; Chen D
Front Immunol; 2023; 14():1260195. PubMed ID: 37868988
[TBL] [Abstract][Full Text] [Related]
3. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
Cao J; Liang Y; Gu JJ; Huang Y; Wang B
Front Genet; 2022; 13():991162. PubMed ID: 36353118
[No Abstract] [Full Text] [Related]
4. Identification and verification of m7G-Related genes as biomarkers for prognosis of sarcoma.
Qin H; Sheng W; Weng J; Li G; Chen Y; Zhu Y; Wang Q; Chen Y; Yang Q; Yu F; Zeng H; Xiong A
Front Genet; 2023; 14():1101683. PubMed ID: 36816047
[No Abstract] [Full Text] [Related]
5. m7G-related genes-NCBP2 and EIF4E3 determine immune contexture in head and neck squamous cell carcinoma by regulating CCL4/CCL5 expression.
Xu X; Zhao Y; Ying Y; Zhu H; Luo J; Mou T; Zhang Z
Mol Carcinog; 2023 Aug; 62(8):1091-1106. PubMed ID: 37067401
[TBL] [Abstract][Full Text] [Related]
6. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.
Liu P; Dong C; Shi H; Yan Z; Zhang J; Liu J
J Gastrointest Oncol; 2022 Dec; 13(6):3169-3182. PubMed ID: 36636051
[TBL] [Abstract][Full Text] [Related]
7. Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer.
Dai D; Zhuang H; Shu M; Chen L; Long C; Wu H; Chen B
Heliyon; 2024 Apr; 10(8):e29326. PubMed ID: 38628712
[TBL] [Abstract][Full Text] [Related]
8. Analysis of m7G-Related signatures in the tumour immune microenvironment and identification of clinical prognostic regulators in breast cancer.
Huang Q; Mo J; Yang H; Ji Y; Huang R; Liu Y; Pan Y
BMC Cancer; 2023 Jun; 23(1):583. PubMed ID: 37353728
[TBL] [Abstract][Full Text] [Related]
9. WDR4 promotes HCC pathogenesis through N
Dong R; Wang C; Tang B; Cheng Y; Peng X; Yang X; Ni B; Li J
Cell Signal; 2024 Jun; 118():111145. PubMed ID: 38493882
[TBL] [Abstract][Full Text] [Related]
10. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
[TBL] [Abstract][Full Text] [Related]
11. M7G methylated core genes (METTL1 and WDR4) and associated RNA risk signatures are associated with prognosis and immune escape in HCC.
Li R; Liu X; Deng K; Wang X
BMC Med Genomics; 2023 Aug; 16(1):179. PubMed ID: 37528384
[TBL] [Abstract][Full Text] [Related]
12. N7-methylguanosine regulatory genes well represented by METTL1 define vastly different prognostic, immune and therapy landscapes in adrenocortical carcinoma.
Xu F; Cai D; Liu S; He K; Chen J; Qu L; Chong T; Li X; Ren B
Am J Cancer Res; 2023; 13(2):538-568. PubMed ID: 36895966
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma.
Zhang Y; Gan W; Ru N; Xue Z; Chen W; Chen Z; Wang H; Zheng X
J Bone Oncol; 2023 Jun; 40():100481. PubMed ID: 37139222
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation.
Li AY; Xiao HN; Zhao ZY; Xiang C; Chen ZY; Wang PX; Xia Y; Yu B; Li H; Xiao T
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9105-9128. PubMed ID: 37171615
[TBL] [Abstract][Full Text] [Related]
15. A novel prognostic signature based on N7-methylguanosine-related long non-coding RNAs in breast cancer.
Huang Z; Lou K; Liu H
Front Genet; 2022; 13():1030275. PubMed ID: 36313442
[TBL] [Abstract][Full Text] [Related]
16. A new prediction model of hepatocellular carcinoma based on N7-methylguanosine modification.
Yang L; Wang YR; Mou ZQ; Xiong PF; Deng K; Wen J; Li J
BMC Gastroenterol; 2023 Apr; 23(1):131. PubMed ID: 37081394
[TBL] [Abstract][Full Text] [Related]
17. Analysis and Validation of the Prognosis ability of the M7GRelated miRNAs in Lung Adenocarcinoma.
Qiu X; Chen Y; Zhu X; Gong Z; Yu F; Zhang P; Song Y; Li H
Asian Pac J Cancer Prev; 2023 Apr; 24(4):1275-1287. PubMed ID: 37116150
[TBL] [Abstract][Full Text] [Related]
18. N7-methylguanosine modification: from regulatory roles to therapeutic implications in cancer.
Cai M; Yang C; Wang Z
Am J Cancer Res; 2023; 13(5):1640-1655. PubMed ID: 37293166
[TBL] [Abstract][Full Text] [Related]
19. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X
Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958
[TBL] [Abstract][Full Text] [Related]
20. m7G-related gene NUDT4 as a novel biomarker promoting cancer cell proliferation in lung adenocarcinoma.
Liu Y; Jiang B; Lin C; Zhu W; Chen D; Sheng Y; Lou Z; Ji Z; Wu C; Wu M
Front Oncol; 2022; 12():1055605. PubMed ID: 36761423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
